As VC-backed start-ups continue to watch and wait for their IPO window, a large syndicate backs an oncology start-up with aspirations to go public
Finance
Emerging Company Profile
Swiss biotech Vandria is restoring energy balance in neurons with its first program, soon to enter the clinic for mild cognitive impairment
Data Byte
J&J and Legend’s CAR T therapy could move into earlier lines; Day One could get its first marketed product
Management Tracks
Plus: Michael Lenardo to become CSO at Calico, and updates from Aveo and Dyadic
BioCentury ISSN 1097-7201